Ironwood Pharmaceuticals (IRWD) Non-Current Debt (2013 - 2026)
Ironwood Pharmaceuticals (IRWD) posted Non-Current Debt of $385.0 million for Q1 2026, little changed sequentially from $385.0 million in Q4 2025, and little changed YoY from $385.0 million in Q1 2025.
Ironwood Pharmaceuticals (IRWD) Non-Current Debt (2013 - 2026) Analysis & Trends
Ironwood Pharmaceuticals has reported Non-Current Debt for 11 years, with the latest figure at $385.0 million in Q1 2026.
- Quarterly Non-Current Debt changed 0.0% year-over-year to $385.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $385.0 million (changed 0.0% YoY) and the FY2025 annual result came in at $385.0 million, changed 0.0% from the prior year.
- Non-Current Debt was little changed at $385.0 million in Q1 2026 per IRWD's latest filing, from $385.0 million in the prior quarter.
- Over five years, Non-Current Debt peaked at $425.0 million in Q2 2024 and troughed at $275.0 million in Q1 2024.
- A 4-year average of $369.6 million and a median of $385.0 million in 2024 frame the typical range for Non-Current Debt.
- The widest YoY moves for Non-Current Debt: up 40.0% in 2025, down 9.41% in 2025.
- Over 4 years, Non-Current Debt stood at $300.0 million in 2023, then advanced by 28.33% to $385.0 million in 2024, then changed by 0.0% to $385.0 million in 2025, then changed by 0.0% to $385.0 million in 2026.
- According to Business Quant data, Non-Current Debt over the past three periods registered $385.0 million, $385.0 million, and $385.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | -8.44 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 12.09 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 9.05 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 27.73 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | - |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 11.61 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | - |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 3.85 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 130.00 Mn |
| 10 | Ironwood Pharmaceuticals | 679.81 Mn | 600.69 Mn | - | 385.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 385.00 Mn |
| Mar 31, 2026 | 385.00 Mn |
| Dec 31, 2025 | 385.00 Mn |
| Sep 30, 2025 | 385.00 Mn |
| Jun 30, 2025 | 385.00 Mn |
| Mar 31, 2025 | 385.00 Mn |
| Dec 31, 2024 | 385.00 Mn |
| Sep 30, 2024 | 400.00 Mn |
| Jun 30, 2024 | 425.00 Mn |
| Mar 31, 2024 | 275.00 Mn |
| Dec 31, 2023 | 300.00 Mn |
| Sep 30, 2023 | 325.00 Mn |
| Jun 30, 2023 | 400.00 Mn |
| Jun 30, 2019 | 78.33 Mn |
| Mar 31, 2019 | 90.14 Mn |
| Dec 31, 2018 | 100.54 Mn |
| Sep 30, 2018 | 108.59 Mn |
| Jun 30, 2018 | 122.61 Mn |
| Mar 31, 2018 | 135.22 Mn |
| Dec 31, 2017 | 146.90 Mn |